drugset / Trial / NCT00074295
S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer
Phase 2
Terminated
19 enrolled
SWOG Cancer Research Network
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Vaccines made from a person's tumor tissue may make the body build an immune response to kill tumor cells. PURPOSE: This phase II trial is studying vaccine therapy to see how well it works in treating patients with stage IIIB or stage IV bronchoalveolar (lung) cancer.
Timeline
- Start
- 2004-03
- Primary completion
- 2007-08
- Completion
- 2007-08
Outcome
Outcome not reported
Stopped: “closed due to lack of availability of vaccine”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GVAX lung cancer vaccine | Vaccine | — | Other |